James Edgemond United Therapeutics Corp (UTHR) insider trading activity

James Edgemond is CFO AND TREASURER of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 8,068 shares of UTHR, which is worth approximately $2.91 Million. The most recent transaction as insider was on Nov 04, 2024, when has been sold 7,778 shares (Common Stock) at a price of $374.02 per share, resulting in proceeds of $2,909,127. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.07K

68.01% 3M change

482.95% 12M change

Total Value Held $2.91 Million

JAMES EDGEMOND Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 04 2024	SELL Open market or private sale	$2,909,127 $374.02 p/Share	7,778 Reduced 49.08%	8,068 Common Stock
Nov 04 2024	BUY Exercise of conversion of derivative security	$991,829 $119.01 p/Share	8,334 Added 49.12%	8,633 Common Stock
Oct 28 2024	SELL Open market or private sale	$2,730,000 $350.0 p/Share	7,800 Reduced 50.94%	7,512 Common Stock
Oct 28 2024	BUY Exercise of conversion of derivative security	$991,829 $119.01 p/Share	8,334 Added 50.75%	8,088 Common Stock
Oct 21 2024	SELL Open market or private sale	$2,855,916 $366.99 p/Share	7,782 Reduced 52.72%	6,978 Common Stock
Oct 21 2024	BUY Exercise of conversion of derivative security	$991,829 $119.01 p/Share	8,334 Added 52.48%	7,545 Common Stock
Oct 14 2024	SELL Open market or private sale	$2,773,016 $355.88 p/Share	7,792 Reduced 54.8%	6,426 Common Stock
Oct 14 2024	BUY Exercise of conversion of derivative security	$1,116,839 $134.01 p/Share	8,334 Added 54.36%	6,998 Common Stock
Oct 07 2024	SELL Open market or private sale	$2,771,078 $355.54 p/Share	7,794 Reduced 56.98%	5,884 Common Stock
Oct 07 2024	BUY Exercise of conversion of derivative security	$991,829 $119.01 p/Share	8,334 Added 56.35%	6,457 Common Stock
Sep 30 2024	SELL Open market or private sale	$2,794,367 $358.62 p/Share	7,792 Reduced 59.32%	5,344 Common Stock
Sep 30 2024	BUY Exercise of conversion of derivative security	$991,829 $119.01 p/Share	8,334 Added 58.48%	5,916 Common Stock
Sep 23 2024	SELL Open market or private sale	$2,760,095 $354.04 p/Share	7,796 Reduced 61.88%	4,802 Common Stock
Sep 23 2024	BUY Exercise of conversion of derivative security	$991,829 $119.01 p/Share	8,334 Added 60.79%	5,376 Common Stock
Sep 16 2024	SELL Open market or private sale	$2,648,527 $339.12 p/Share	7,810 Reduced 64.68%	4,264 Common Stock
Sep 16 2024	BUY Exercise of conversion of derivative security	$991,829 $119.01 p/Share	8,334 Added 63.24%	4,845 Common Stock
Sep 09 2024	SELL Open market or private sale	$2,694,888 $345.41 p/Share	7,802 Reduced 67.6%	3,740 Common Stock
Sep 09 2024	BUY Exercise of conversion of derivative security	$991,591 $119.01 p/Share	8,332 Added 65.87%	4,318 Common Stock
Sep 03 2024	SELL Open market or private sale	$2,821,050 $362.37 p/Share	7,785 Reduced 71.12%	3,162 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$991,591 $119.01 p/Share	8,332 Added 69.07%	3,731 Common Stock
Aug 26 2024	SELL Open market or private sale	$2,710,932 $347.6 p/Share	7,799 Reduced 74.89%	2,615 Common Stock
Aug 26 2024	BUY Exercise of conversion of derivative security	$991,591 $119.01 p/Share	8,332 Added 72.31%	3,191 Common Stock
Aug 19 2024	SELL Open market or private sale	$2,575,568 $329.02 p/Share	7,828 Reduced 78.99%	2,082 Common Stock
Aug 19 2024	BUY Exercise of conversion of derivative security	$991,591 $119.01 p/Share	8,332 Added 75.71%	2,673 Common Stock
May 15 2024	SELL Open market or private sale	$10,951,230 $272.69 p/Share	40,160 Reduced 96.22%	1,578 Common Stock

James Edgemond

CFO AND TREASURER

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account